Letters

Reduction of postoperative mortality and morbidity

BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7295.1182 (Published 12 May 2001) Cite this as: BMJ 2001;322:1182

Little information was given on inclusion criteria

  1. Timothy J McCulloch, staff specialist anaesthetist,
  2. John A Loadsman, staff specialist anaesthetist
  1. Department of Anaesthetics, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia
  2. Nuffield Department of Anaesthetics, John Radcliffe Hospital, Headington, Oxford OX3 9DU
  3. Clinical Trials Research Unit, Department of Medicine
  4. Division of Anaethesiology University of Auckland, Private Bag 92019, Auckland 1, New Zealand
  5. Department of Anaesthetics, Green Lane Hospital, Epsom, Auckland 1003
  6. Department of Anesthesiology, Intensive Care and Pain Therapy, Catharina Hospital, NL-5623 EJ Eindhoven, Netherlands

    EDITOR—Rodgers et al report a meta-analysis of 141 trials comparing general anaesthesia with neuraxial blocks.1 They conclude that their data should result in more widespread use of spinal or epidural anaesthesia. The challenge for clinicians is deciding which of their patients (if any) these results apply to, but Rodgers et al provided little information about the inclusion criteria for the trials examined. The applicability of a meta-analysis is difficult to assess when heterogeneous patient groups are combined. Also, although a spinal or epidural anaesthetic might be reasonably standard, there are many general anaesthetic agents and these may not be comparable.

    Figure 1 of the meta-analysis shows that four trials contributed 31 deaths to the overall mortality difference of 41.25 In those four studies the mortality from general anaesthesia ranged from 8% to 27%, compared with 3.1% for all trials combined.

    We wonder whether any information was collated on antithrombosis prophylaxis. In 2001 most patients at risk of venous thrombosis having a general anaesthetic will receive prophylaxis including anticoagulation drugs at low doses. Of the four trials referred to above, three are over 15 years old, and at least one specifically excluded patients receiving low dose anticoagulation.3

    Figure 2 of the meta-analysis indicates an apparent benefit of neuraxial block in orthopaedic patients.1 Mortality after vascular, urological, and general surgery showed no significant difference. We therefore question the conclusion …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe